Rolls-Royce denies report of IPO plans for small nuclear reactor unit

I guess they have probably popped up again then… For the second time in a month this is trying hard to break out. The good news is starting to flow – the Glypromate first phase 3 trial is going to wrap up much faster due to better quality of data (doesn’t necessarily mean better result,…

I had a deep dive into KPG to see if I could find any conviction given the strong run in share price and the enthusiasm some investors I respect, had for the business. In the end I couldn’t find the conviction and here are a few of the reasons. The debt still troubles me, a…

“At current rates, the U.S. national debt is growing by a remarkable $1 trillion about every 100 days, equal to roughly $3.6 trillion per year. As the national debt has ballooned, debt payments even exceeded Medicaid outlays in 2023—one of the government’s largest expenditures. On average, the U.S. spent more than $2 billion per day…